Which has the lower trailing P/E, BMY or DHR?

BMY has the lower trailing P/E: BMY trades at 17.57 and DHR at 34.90. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or DHR?

Over the past five years, BMY grew revenue faster — BMY at a 2.52% CAGR versus DHR at 1.97%.

Does BMY or DHR pay a bigger dividend?

BMY yields 4.00% and DHR yields 0.53% based on trailing dividends and the latest price.

Is BMY or DHR more profitable?

DHR runs the higher net margin — BMY at 15.01% versus DHR at 15.95%.

How have BMY and DHR total returns compared?

Over the past 10 years, BMY delivered 2.02% and DHR delivered 11.18% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Danaher Corporation (DHR)

A side-by-side comparison of Bristol-Myers Squibb Company and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

DHR

Danaher Corporation

$139.95B

$199.08HealthcareDelayed quote: Jul 28, 2026, 3:59 PM EDT

Total return — BMY vs DHR

growth of $100 · dividends reinvested · last 30y

BMY +735.9%DHR +6466.3%DHR compounded faster

Log scale — wide-divergence pair

BMY DHR

BMY vs DHR: by the numbers

•DHR is the larger company ($139.95B vs $129.88B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 34.90 P/E), one valuation lens rather than an overall verdict.
•DHR converts more revenue to profit (15.95% vs 15.01% net margin).
•BMY grew revenue faster over the past five years (2.52% vs 1.97% CAGR).
•BMY pays the higher dividend yield (4.00% vs 0.53%).

Metrics side by side

Valuation

Metric	BMY	DHR
P/E ratio	17.57	34.90
Forward P/E	9.86	23.14
P/S ratio	2.64	5.54
P/B ratio	6.37	2.64
PEG ratio	1.87	87.26
EV / EBITDA	10.34	24.56
FCF yield	9.31%	3.93%

Profitability

Metric	BMY	DHR
Gross margin	68.75%	58.51%
Operating margin	25.67%	20.42%
Net margin	15.01%	15.95%
ROE	36.25%	7.61%
ROIC	13.90%	5.72%

Dividends

Metric	BMY	DHR
Dividend yield	4.00%	0.53%
Payout ratio	72.25%	20.51%

Growth (annualized)

Metric	BMY	DHR
Revenue CAGR (5Y)	2.52%	1.97%
EPS CAGR (5Y)	9.38%	0.40%
FCF CAGR (5Y)	-2.50%	-2.83%
Total return CAGR (5Y)	2.73%	-4.81%

Frequently asked

Which has the lower trailing P/E, BMY or DHR?: BMY has the lower trailing P/E: BMY trades at 17.57 and DHR at 34.90. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or DHR?: Over the past five years, BMY grew revenue faster — BMY at a 2.52% CAGR versus DHR at 1.97%.
Does BMY or DHR pay a bigger dividend?: BMY yields 4.00% and DHR yields 0.53% based on trailing dividends and the latest price.
Is BMY or DHR more profitable?: DHR runs the higher net margin — BMY at 15.01% versus DHR at 15.95%.
How have BMY and DHR total returns compared?: Over the past 10 years, BMY delivered 2.02% and DHR delivered 11.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full DHR analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Danaher P/E ratio Bristol-Myers Squibb dividend yield Danaher dividend yield Bristol-Myers Squibb ROE Danaher ROE Bristol-Myers Squibb operating margin Danaher operating margin Bristol-Myers Squibb revenue growth Danaher revenue growth Bristol-Myers Squibb free cash flow Danaher free cash flow

Bristol-Myers Squibb & Danaher appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.